A large prospective cohort study finds no evidence that take-home naloxone increases risky drug use behaviors. Injection frequency, opioid use, benzodiazepine use, and using alone remained unchanged—reinforcing naloxone’s role as a lifesaving harm-reduction tool without unintended risk compensation.